Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours.
about
Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathwayMechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines.Topical administration of regorafenib eye drops: Phase I dose-escalation study in healthy volunteers.The safety of regorafenib for the treatment of gastrointestinal stromal tumors.Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling.
P2860
Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regorafenib: A Review of Its U ...... trointestinal Stromal Tumours.
@en
type
label
Regorafenib: A Review of Its U ...... trointestinal Stromal Tumours.
@en
prefLabel
Regorafenib: A Review of Its U ...... trointestinal Stromal Tumours.
@en
P2860
P1433
P1476
Regorafenib: A Review of Its U ...... trointestinal Stromal Tumours.
@en
P2093
Matt Shirley
P2860
P2888
P304
P356
10.1007/S40265-015-0406-X
P577
2015-06-01T00:00:00Z
P6179
1014046820